BAMBOOSHEALTH (02293) announced its annual results for the year ended June 30, 2025. Revenue from customer contracts reached HK$74.404 million, representing a year-on-year decline of 21.5%. Net profit amounted to HK$17.541 million, down 43.3% compared to the previous year. Basic earnings per share stood at HK$4.38 cents, with a proposed final dividend of HK$1.50 cents per share.
To maintain a large and diversified pool of registered healthcare professionals and capitalize on development opportunities, the Group offers extensive member benefits to attract and retain registered healthcare professionals. As of June 30, 2025, approximately 32,000 healthcare professionals were registered with the Group, an increase of about 2,200 or 7.4% from 29,800 in the previous year.